Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
31.7M
-
Shares change
-
+9.34M
-
Total reported value, excl. options
-
$376M
-
Value change
-
+$119M
-
Put/Call ratio
-
1.26
-
Number of buys
-
59
-
Number of sells
-
-41
-
Price
-
$11.88
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2021
134 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.7M shares
of 60M outstanding shares and own 52.73% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (8.7M shares), First Light Asset Management, LLC (2.62M shares), Avidity Partners Management LP (2.55M shares), STATE STREET CORP (2.42M shares), VANGUARD GROUP INC (2.05M shares), BlackRock Inc. (1.05M shares), TWO SIGMA INVESTMENTS, LP (882K shares), TWO SIGMA ADVISERS, LP (835K shares), FMR LLC (760K shares), and Woodline Partners LP (730K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.